Home

Differences

This shows you the differences between two versions of the page.

Link to this comparison view

Both sides previous revision Previous revision
Next revision
Previous revision
home:diseases:celiac [07.19.2019]
sallieq [recent research]
home:diseases:celiac [04.26.2020] (current)
sallieq [recent research]
Line 69: Line 69:
  
 In 2015 I saw that 6 individuals in the USA were suing maker of Benicar. (//presumably for bowel immunopathology caused by cytokines//). //Somewhere else I found that 1.9 million individuals are currently taking Olmesartan Medoxomil.//  //6 in 1.9 million ? Seems pretty rare to me.// (//Editor//) In 2015 I saw that 6 individuals in the USA were suing maker of Benicar. (//presumably for bowel immunopathology caused by cytokines//). //Somewhere else I found that 1.9 million individuals are currently taking Olmesartan Medoxomil.//  //6 in 1.9 million ? Seems pretty rare to me.// (//Editor//)
 +
 +Gluten in "gluten-free" manufactured foods in Australia: a cross-sectional study.  (({{pubmed>long:30404591}})) PMID 30404591
 +
  
 2018 data show that OLM is an Nrf2 activator, NFkB inhibitor and apoptosis inhibitor in an experimental model of ulcerative colitis. Overall, the study indicates that OLM shows promise as a potential therapy for the treatment of human inflammatory bowel diseases.  2018 data show that OLM is an Nrf2 activator, NFkB inhibitor and apoptosis inhibitor in an experimental model of ulcerative colitis. Overall, the study indicates that OLM shows promise as a potential therapy for the treatment of human inflammatory bowel diseases. 
 (({{pubmed>long:30594690}})) (({{pubmed>long:30594690}}))
 +
 +Research associated with J Tye-Din   (({{pubmed>long:    20650871}})) ,  (({{pubmed>long:17629515}})) ,  (({{pubmed>long:888}})) ,  (({{pubmed>long:    19942485}})) ,  (({{pubmed>long:23981538}})) ,  (({{pubmed>long:16099789}})) ,  (({{pubmed>long:888}})) 
 +
 +
  
 {{tag>diseases }} {{tag>diseases }}
home/diseases/celiac.1563574171.txt.gz · Last modified: 07.19.2019 by sallieq
© 2015, Autoimmunity Research Foundation. All Rights Reserved.